20059 ⎘
Medicinal preparations characterised by special physical form; Dispersions; Emulsions; Emulsions ; Emulsion preconcentrates; Micelles Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
PHARMACEUTICAL DELIVERY SYSTEMS FOR HYDROPHOBIC DRUGS AND COMPOSITIONS COMPRISING SAME
#1202Compositions and methods of tumor treatment utilizing nanoparticles
#1203Use of biocompatible microdroplets for the treatment of atherosclerosis, heart disease and stroke
#1204Nanoemulsion compositions of taxoid drugs, and methods for the use thereof to target cancer cells and cancer stem cells
#1205Topical pharmaceutical composition based on semifluorinated alkanes
#1206BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF
#1207PHARMACEUTICAL DELIVERY SYSTEMS FOR HYDROPHOBIC DRUGS AND COMPOSITIONS COMPRISING SAME
#1208PHARMACEUTICAL DELIVERY SYSTEMS FOR HYDROPHOBIC DRUGS AND COMPOSITIONS COMPRISING SAME
#1209EMULSION FORMULATIONS
#1210Nanoemulsions
#1211WATER-SOLUBLE PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE THERAPEUTICALLY ACTIVE SUBSTANCE AND AT LEAST ONE SUBSTANCE CAPABLE OF FORMING MICELLES
#1212Ophthalmic compositions
#1213Vitamin A composition
#1214C-Rel-specific siRNA and its use for preventing and treating autoimmune psoriasis
#1215Compositions of jasmonate compounds and methods of use
#1216Formulations and carrier systems including farnesylthiosalicylic moieties
#1217Wax foamable vehicle and pharmaceutical compositions thereof
#1218Self-emulsifying composition of omega-3 fatty acid
#1219Lipid nanoparticles comprising lipophilic anti-inflammatory agents and methods of use thereof
#1220COMPOSITIONS COMPRISING MACROMOLECULAR ASSEMBLIES OF LIPID AND SURFACTANT
#1221Cyclosporine analogue mixtures and their use as immunomodulating agents
#1222LIPID ENCAPSULATED GAS MICROSPHERE COMPOSITIONS AND RELATED METHODS
#1223Formulations for targeted release of agents under low pH conditions and methods of use thereof
#1224Nanoemulsion respiratory syncytial virus (RSV) subunit vaccine
#1225Oral administration of unstable or poorly-absorbed drugs
#1226Anti-RDS compounds and method of manufacture and administration thereof to induce dopamine homeostatis
#1227Amphiphilic entity nanoparticles
#1228OIL-IN-WATER NANOEMULSIONS
#1229SELF-EMULSIFYING COMPOSITION OF OMEGA3 FATTY ACID
#1230Chemically stable compositions of a pharmaceutical active agent in a multi- chambered delivery system for mucosal delivery
#1231Whey Protein Micelles to Enhance Muscle Mass and Performance
#1232Vaginal delivery systems containing selective estrogen receptor modulator (SERM) and uses thereof
#1233Use of Docosahexaenoic Glycerides For The Treatment Of Tumorous Diseases
#1234Polymers and polymeric nanogels with hydrophilics encapsulation and release capabilities and methods thereof
#1235Treatment Method and Product for Uterine Fibroids using Purified Collagenase
#1236Sucrose ester based cationic gene vector and preparation method thereof
#1237JANUS NANOPARTICLE AND METHOD FOR PRODUCING THE SAME
#1238Block copolymer and micelle compositions and methods of use thereof
#1239MUCOADHESIVE EMOLLIENT
#1240Crosslinked nanoparticle composition
#1241ENCAPSULATION OF AN OIL CONTAINING UNSATURATED FATTY ACIDS
#1242TEAT PACK MATERIAL FOR LACTATING LIVESTOCK, KIT FOR FORMING TEAT PACK FOR LACTATING LIVESTOCK, AND METHOD FOR PREVENTING MASTITIS IN LACTATING LIVESTOCK
#1243METHODS OF MANUFACTURING VISCOUS LIQUID PHARMACEUTICAL FORMULATIONS
#1244Micellar polypeptide vaccine having pegylated phospholipids as carrier
#1245Botulinum nanoemulsions
#1246Antileishmanial compositions and methods of use
#1247CAROTENOID PARTICLES AND USES THEREOF
#1248Emulsion and emulsion preconcentrate compositions comprising omega-3 fatty acids and uses thereof are disclosed
#1249METHODS OF DIAGNOSIS AND TREATMENT
#1250Programmed cargo release using nucleic acid-stabilized micelles
#1251Stable nimodipine parenteral formulation
#1252Stable nimodipine parenteral formulation
#1253Administration of berberine metabolites
#1254Nanocarriers for drug delivery
#1255BIODEGRADABLE IN SITU FORMING MICROPARTICLES AND METHODS FOR PRODUCING THE SAME
#1256POLY (E-CAPROLACTONE)-ETHOXYLATED FATTY ALCOHOL COPOLYMERS
#1257MEDICINAL COMPOSITION FOR ENHANCED DELIVERY OF TRITERPENES
#1258Topical and transdermal delivery of HIF-1 modulators to prevent and treat chronic wounds
#1259Composition Comprising Dual Ionic pH-Sensitive Copolymer for Delivering SDF-1 Topically to the Brain and the Use Thereof
#1260Method for reducing damage caused by free radicals
#1261Parenteral bioactive substance delivery composition based on low molecular weight methyl cellulose
#1262Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
#1263Lipid sterilization method
#1264ENDOTOXIN NANOVESICLES: HYDROPHILIC GOLD NANODOTS CONTROL LIPOPOLYSACCHARIDE ASSEMBLY FOR MODULATING IMMUNOLOGICAL RESPONSES
#1265ANTI-CANCER AGENT DELIVERY VEHICLES CAPABLE OF IMPROVED LOADING
#1266Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states
#1267ANTI-CANCER AGENT FOR USE IN COMBINATION THERAPY OF HIGH INTENSITY FOCUSED ULTRASOUND THERAPY AND ANTI-CANCER AGENT THERAPY
#1268Block copolymers for stable micelles
#1269Orally administrable composition
#1270NANOEMULSIONS
#1271Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease
#1272Omega-3 fatty acid ester compositions
#1273Block copolymers for stable micelles
#1274Magnetic control of gene delivery in vivo
#1275Micellic assemblies
#1276FOAM PREPARED FROM NANOEMULSIONS AND USES
#1277Amphiphilic block copolymers for delivery of active agents
#1278SELF-ASSEMBLING MOLECULES THAT ACCUMULATE IN ACIDIC TUMOR MICROENVIRONMENTS
#1279Ophthalmic composition comprising cyclosporine and trehalose
#1280INTRANSAL DELIVERY OF CURCUMIN
#1281Ceramide-Rubusoside Nanomicelles and Their Use in Cancer Therapy
#1282Method of treating a CNS disorder using a water-soluble histone deacetylase inhibitor
#1283Emulsion formulations of an NK-1 receptor antagonist and uses thereof
#1284Silicone-based biophotonic compositions and uses thereof
#1285Cationic oil-in-water emulsions
#1286Emulsions by condensation
#1287Compositions comprising granulocyte-macrophage colony-stimulating factor for the treatment of inflammatory bowel disease
#1288Compound prescription colloidal eyedrop gel and methods of making the same
#1289Biomarker specific amphiphilic nanoparticles
#1290Botulinum nanoemulsions
#1291Composition for mRNA delivery
#1292METHODS OF DELIVERING HEPARIN BINDING EPIDERMAL GROWTH FACTOR USING STEM CELL GENERATED EXOSOMES
#1293Microencapsulated cannabinoid compositions
#1294Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
#1295APTAMERS FOR TOPICAL DELIVERY
#1296Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
#1297Alternating ring-opening metathesis polymerization
#1298Pharmaceutical composition containing docetaxel
#1299LIPID PARTICLES WITH CATIONIC LIPIDS FOR RNA DELIVERY
#1300Skin external preparation and skin irritation-reducing method
#1301CHEMICALLY STABLE COMPOSITIONS OF A PHARMACEUTICAL ACTIVE AGENT IN A MULTI-CHAMBERED DELIVERY SYSTEM FOR OROMUCOSAL DELIVERY
#1302Antimicrobial preparations, methods for preparing the same and uses thereof to combat microorganisms
#1303Antitumor composition based on hyaluronic acid and inorganic nanoparticles, method of preparation thereof and use thereof
#1304Amphiphilic polymer
#1305Pharmaceutical oil-in-water nano-emulsion
#1306BEVERAGE NANOEMULSTIONS PRODUCED BY HIGH SHEAR PROCESSING
#1307Surfactant-stripped micelle compositions with high cargo to surfactant ratio
#1308SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE
#1309ENZYMATIC SYNTHESIS OF POLY(AMINE-CO-ESTERS) AND METHODS OF USE THEREOF FOR GENE DELIVERY
#1310HYPERBRANCHED POLYGLYCEROL SULFATES WITH HYDROPHOBIC CORES
#1311Solid oral dosage form of lipophilic compounds
#1312Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof
#1313Nanoemulsions having reversible continuous and dispersed phases
#1314LIQUID PHARMACEUTICAL FORMULATIONS OF TETRAIODOTHYRONINE
#1315Fluoropolymer emulsions with perhalogenated stabilizer for the delivery of hydrophobic drugs
#1316TOPICAL NANOEMULSION THERAPY FOR WOUNDS
#1317Oral taxane compositions and methods
#1318NANOPARTICLE COMPOSITIONS AND COMPONENTS THEREOF
#1319Targeted extracellular vesicles comprising membrane proteins with engineered glycosylation sites
#1320Methods of folding a graft copolymer with dual anticancer drugs and related applications
#1321OIL/SURFACTANT MIXTURES FOR SELF-EMULSIFICATION
#1322Therapeutic agent for use in the treatment of infections
#1323Topical pharmaceutical compositions containing nanodroplets for the treatment of psoriasis
#1324COMPOSITIONS AND METHODS FOR THE TREATMENT OF SARCOIDOSIS
#1325Bis-polymer lipid-peptide conjugates and nanoparticles thereof
#1326Carotenoid particles and uses thereof
#1327Fluoropolymer emulsions with branched semifluorinated block copolymer or phospholipid surfactant for the delivery of hydrophobic drugs
#1328Emulsified krill phospholipid compositions
#1329Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissection
#1330Nanolipidic particle assembly populations
#1331VITAMIN E-BASED NANOCARRIERS FOR DRUG DELIVERY AND METHODS OF MAKING AND USING THE SAME
#1332METHODS AND RELATED COMPOSITIONS FOR THE TREATMENT OF CANCER
#1333Liquid enteral nutritional composition with a low monovalent metal ion content
#1334STABILIZED HIGH DRUG LOAD NANOCARRIERS, METHODS FOR THEIR PREPARATION AND USE THEREOF
#1335FOOD MATRICES AND METHODS OF MAKING AND USING
#1336PHARMACEUTICAL COMPOSITION WITH IMPROVED STORAGE STABILITY AND METHOD FOR PREPARING THE SAME
#1337PHARMACEUTICAL COMPOSITION WITH IMPROVED STORAGE STABILITY AND METHOD FOR PREPARING THE SAME
#1338PHARMACEUTICAL COMPOSITION WITH IMPROVED STORAGE STABILITY AND METHOD FOR PREPARING THE SAME
#1339Drug carrier and manufacturing method thereof
#1340Stable pharmaceutical composition of clopidogrel free base for oral and parenteral delivery
#1341Methods and compositions for nanoemulsion vaccine formulations
#1342Polyphosphazene delivery system for inorganic nanocrystals
#1343Nanostructured gels capable of controlled release of entrapped agents
#1344METHOD FOR EMULSIFYING A TRIEPITOPE PEPTIDE WITH MONTANIDE AND KITS FOR PERFORMING THE SAME
#1345Compositions and methods for improved encapsulation of functional proteins in polymeric vesicles
#1346MICELLE CONTAINING BUBBLES FOR DRUG DELIVERY AND METHOD FOR MANUFACTURING SAME
#1347MetAP-2 inhibitor polymersomes for therapeutic administration
#1348Macrolide particulates, methods for preparation, and medical devices associated therewith
#1349Targeted Active Release System Comprising Solid Lipid Nano-Particles
#1350Polylactide compositions and uses thereof
#1351Targeting microbubbles
#1352Pharmaceutical compositions
#1353Methods for reducing immune responses
#1354MetAP-2 inhibitor polymersomes for therapeutic administration
#1355Pharmaceutical dosage forms comprising 6′-fluoro-(N-methyl- or N,N-dimethyl-)-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine
#1356Compositions for inducing antigen-specific tolerance
#1357Methods for induction of antigen-specific immune tolerance
#1358Compositions for generating immune tolerance by targeting erythrocytes
#1359Parenteral compositions of celecoxib
#1360Inhibitors of paxillin function and related compositions and methods
#1361IRON STABILIZED MICELLES AS MAGNETIC CONTRAST AGENTS
#1362Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
#1363Immediate release phospholipid-coated therapeutic agent nanoparticles and related methods
#1364Means and methods for ocular drug delivery
#1365Functional Micelles for Hard Tissue Targeted Delivery of Chemicals
#1366TOPICAL LIPOLYSIS COMPOSITIONS AND METHODS
#1367BIOCOMPATIBLE POLYACRYLATE COMPOSITIONS AND METHODS OF USE
#1368Magnetic nanoparticles functionalized with catechol, production and use thereof
#1369Amphiphilic dendron-coils, micelles thereof and uses
#1370Racecadotril compositions
#1371Oral pharmaceutical products and methods of use combining testosterone esters with hypolipidemic agents
#1372Pharmaceutical microemulsion immobilized in a thin polymer matrix and methods of making them
#1373Manganese ion coated nanoparticles for delivery of compositions into the central nervous system by nasal insufflation
#1374SYSTEM FOR CO-DELIVERY OF POLYNUCLEOTIDES AND DRUGS INTO PROTEASE-EXPRESSING CELLS
#1375Aqueous Systems For The Preparation Of Lipid Based Pharmaceutical Compounds; Compositions, Methods, And Uses Thereof
#1376ROS-DEGRADEABLE HYDROGELS
#1377Composition for an immunomodulation
#1378Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissection
#1379Polyol-in-Oil-Emulsions For Dermal Delivery
#1380Polymer platform to prepare nanohydrogel
#1381METHODS AND COMPOSITIONS FOR USE IN AQUACULTURE
#1382MICELLE-BASED DELIVERY OF DERMAL THERAPEUTIC MATERIALS
#1383Crosslinked Polysaccharide Beads and Their Biomedical Uses
#1384Prodrug compositions, prodrug nanoparticles, and methods of use thereof
#1385Ultrasound-triggerable agents for tissue engineering
#1386Pharmaceutical composition
#1387Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity
#1388METHODS AND COMPOSITIONS FOR TREATING SEPSIS
#1389Pharmaceutical compositions of carotenoid chylomicrons
#1390MICELLE COMPOSITIONS AND PROCESS FOR THE PREPARATION THEREOF
#1391Nanoparticles and nanoparticle compositions
#1392Block copolymers for stable micelles
#1393Stable liquid formulations of volatile gas anesthetics
#1394Block copolymers and uses thereof
#1395Functional, cross-linked nanostructures for tandem optical imaging and therapy
#1396Topical formulations and uses thereof
#1397Topical formulations and uses thereof
#1398Non-liposomal systems for nucleic acid delivery
#1399Enzymatic synthesis of poly(amine-co-esters) and methods of use thereof for gene delivery
#1400Micellic assemblies
#1401Use of icaritin in preparing medicament for preventing or treating hematocytopenia
#1402Solution solubilization composition of insoluble material and method for solubilizing insoluble material using same
#1403Pharmaceutical dosage forms fabricated with nanomaterials
#1404Lipid particles with asymmetric cationic lipids for RNA delivery
#1405Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
#1406Crosslinked nanoparticle composition
#1407Polysialic acid-polycaprolactone micelles for drug delivery
#1408Methods and formulations for transdermal administration
#1409Treatment for chemotherapy-induced cognitive impairment
#1410Sugar ester nanoparticle stabilizers
#14112,2′,6,6′-tetraisopropyl-4,4′-biphenol lipid microsphere preparations and preparation methods therefor
#1412Multicomponent, internally structured nanoemulsions and methods of production
#1413Propofol formulations with non-reactive container closures
#1414Mixed micelles
#1415OMEGA-3 FATTY ACID ESTER COMPOSITIONS
#1416OMEGA-3 FATTY ACID ESTER COMPOSITIONS
#1417EMULSION CONTAINING TWO OILS AND STABILIZERS
#1418Polymeric micelle particle comprising anionic drugs and method of preparing the same
#1419Block copolymer and micelle compositions and methods of use thereof
#1420Aqueous solution formulation and method for manufacturing same
#1421Notch 1 specific siRNA molecule
#1422Limit size lipid nanoparticles and related methods
#1423Dermal Delivery
#1424Natural combination hormone replacement formulations and therapies
#1425Nanocomplexes for co-delivering a drug and siRNA and uses thereof
#1426Delivery and Controlled Release of Encapsulated Lipophilic Nutrients
#1427Arranging interaction and back pressure chambers for microfluidization
#1428Compositions and kits for treating pruritus and methods of using the same
#1429Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
#1430Mineralizing biosurfactant used for nucleating silica
#1431SOLID FORMULATIONS OF LIQUID BIOLOGICALLY ACTIVE AGENTS
#1432Use of Docosahexaenoic Glycerides For The Treatment Of Tumorous Diseases
#1433COMPOSITIONS CONTAINING NON-POLAR COMPOUNDS
#1434Nucleic acid-encapsulating polymer micelle complex and method for producing same
#1435Polymer, and pharmaceutical composition employing the same
#1436Ceramide reversal of multi-drug resistance
#1437Branched amphipathic block polymer and molecular aggregate and drug delivery system using same
#1438Targeted Nanocarrier Systems for Delivery of Actives Across Biological Membranes
#1439Omega-3 fatty acid ester compositions unitary pharmaceutical dosage forms
#1440Composition containing polycationic triblock copolymer, polyanionic polymer and physiologically active peptide
#1441SiRNA phospholipid conjugate
#1442NANOEMULSIONS OF HYDROPHOBIC PLATINUM DERIVATIVES
#1443Alternating ring-opening metathesis polymerization
#1444Menthol-based nanoparticles for drug delivery
#1445NANOEMULSION THERAPEUTIC COMPOSITIONS AND METHODS OF USING THE SAME
#1446Self-nanoemulsion of poorly soluble drugs
#1447Treatment for Chemotherapy-Induced Peripheral Neuropathy
#1448Self-emulsifying composition of ω3 fatty acid
#1449Composition comprising oil drops
#1450Fluorescent polymers and applications thereof
#1451Methoxypolyethylene glycol-polylactic acid block copolymer and preparation method thereof
#1452Hydrophobic Preparations
#1453Pharmaceutical compositions of Anisomelic acid and the use thereof
#1454GEL COMPOSITIONS
#1455Docetaxel nano-polymer micelle lyophilized preparation and preparation method thereof
#1456Curcumin solubilisate
#1457Formulations and carrier systems including compound interactive domains
#1458Circulation of components during microfluidization and/or homogenization of emulsions
#1459Method for preparing nanohydrogel
#1460Nanoparticles and nanoemulsions
#1461Hydrophobically modified antisense oligonucleotides comprising a ketal group
#1462CELL PENETRATING PEPTIDE INTRODUCED DRUG-DELIVERY CARRIER COMPRISING MACROMOLECULE
#1463METHOD OF DELIVERING AN ANTI-CANCER AGENT TO A CELL
#1464Novel Process
#1465OPHTHALMIC NANOEMULSION COMPOSITION CONTAINING CYCLOSPORINE AND METHOD FOR PREPARING SAME
#1466Niacin formulation
#1467Cyclosporine analogue mixtures and their use as immunomodulating agents
#1468Nanoparticles for drug delivery comprising albumin having a polymer chain coupled thereto
#1469Nanoemulsion influenza vaccine
#1470OPHTHALMIC COMPOSITION, METHOD FOR PREPARING THE SAME, AND USE OF THE SAME
#1471Amphiphilic compounds
#1472Therapeutic nanoparticles and related compositions, methods and systems
#1473Particulate pharmaceutical composition
#1474Pharmaceutical compositions of carotenoid chylomicrons
#1475Biodegradable copolymers, systems including the copolymers, and methods of forming and using same
#1476Nanoparticles, composed of sterol and saponin from for use in pharmaceutical compositions
#1477Botulinum toxin and the treatment of primary disorders of mood and affect
#1478Enzyme delivery systems and methods of preparation and use
#1479Parenteral diclofenac composition
#1480Non-liposomal systems for nucleic acid delivery
#1481Immunogenic composition in emulsion form
#1482Cannabinoid formulations
#1483Lipid nanomaterial containing lysophosphatidylcholine or derivative thereof and method for preparing same
#1484Polypeptide based block copolymer and the process for the preparation thereof, and the polymer micelles using the same
#1485Oil-in-water method for making polymeric implants containing a hypotensive lipid
#1486Transdermal Drug Delivery Using Amphiphilic Dendron-Coil Micelles
#1487Nanoparticle Delivery of TLR Agonists and Antigens
#1488PHARMACEUTICAL COMPOSITION FOR ENHANCED TRANSMUCOSAL ADMINSTRATION OF BENZODIAZEPINES
#1489LIQUID TOPICAL PHARMACEUTICAL NANO-EMULSION FORMULATIONS
#1490Block copolymers for stable micelles
#1491Assembly of micelle aggregates of surfactant micelles and silver nanoparticles and use as antibacterial agent
#1492Porous silica gel as a carrier for liquid technologies
#1493Modified RSV F proteins and methods of their use
#1494METHODS OF TREATMENT USING CADOTRIL COMPOSITIONS
#1495Curcumin solubilisate
#1496Enzyme delivery systems and methods of preparation and use
#1497Compositions and methods for making and using nanoemulsions
#1498Stable micelles of fatty acid esters for the treatment of disease states
#1499Stable micelles of fatty acid esters for the treatment of macular degeneration and primary sclerosing cholangitis
#1500Stable micelles of fatty acid esters for the treatment of non-alcoholic fatty liver diseases